Executive record
Sam Martin
Senior Vice President, Chief Financial Officer and Secretary at Celldex Therapeutics, Inc.
More
Alpha ID: alpha:person:sam-martinVersion: public-0As of: 2026-10-03
- Executive
Leadership, in context.
Connect capital, control, accountability, and evidence.
Explore the record
ResponsibilitiesInspect board appointments and committee mandates.ExperienceReview career history and qualifications in context.Economic interestsExamine disclosed incentives and ownership.Key Claims
Biography
Sam Martin serves as Senior Vice President and Chief Financial Officer of Celldex Therapeutics.
Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.
Board service
Board service coverage
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageExecutive career
- Current · dates not publishedSenior Vice President, Chief Financial Officer and Secretary · Celldex Therapeutics, Inc.
- 2026 to end not publishedExecutive title: Senior Vice President and Chief Financial Officer · Organization not publishedCLDX DEF 14A executive officers
- Dates not publishedExecutive title: Senior Vice President, Chief Financial Officer and Secretary · Organization not published
Claims
Compensation
Compensation coverage
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageConflicts and accountability
Alpha has not published independence, related-party, proceedings or disciplinary Claims for this record. This is not a finding that none exist.
Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.
Evidence, history and coverage
Additional published Claims
Published evidence records
2 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.
CLDX DEF 14A executive officers
sec filing · Source published: Apr 29, 2026 · Retrieved: May 4, 2026
Supports 5 claims
- AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 4, 2026
- Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 4, 2026
- Executive company: Executive at Celldex Therapeutics, Inc. · Claim reviewed: May 4, 2026
- Executive title: Executive title: Senior Vice President and Chief Financial Officer · Claim reviewed: May 4, 2026
- Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 4, 2026
Open source
sec def 14a · Source published: Apr 29, 2026 · Retrieved: Sep 6, 2026
Supports 2 claims
- Professional Role: Senior Vice President, Chief Financial Officer and Secretary at Celldex Therapeutics, Inc. · Claim reviewed: Sep 6, 2026
- Executive title: Executive title: Senior Vice President, Chief Financial Officer and Secretary · Claim reviewed: Sep 6, 2026
No published record changes are available in this projection.
Identity
unclaimed
Evidence
source reported
Evaluation
Unknown
Monitoring
Unknown
Authority
Unknown
Freshness
Observed 2026-10-03
- Biography
- published
- Board service
- not observed
- Executive career
- published
- Education and qualifications
- not observed
- Compensation
- not observed
- Conflicts and accountability
- not observed
- Background screening
- out of scope